Insulin glargine is a type of insulin. Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as quick energy. Also, insulin helps us store energy that we can use later. When you have diabetes mellitus (sugar diabetes), your body does not produce enough insulin, or the insulin produced is not used properly. This causes you to have too much sugar in your blood. Like other types of insulin, insulin glargine is used to keep your blood sugar level close to normal. Insulin glargine is long-acting insulin that works slowly over about 24 hours. You may have to use insulin glargine in combination with another type of insulin or with a type of oral diabetes medicine to keep your blood sugar under control.

Transition from other insulin to Lantus When changing from a treatment regimen with an intermediate or long-acting insulin to a regimen with Lantus, a change of the dose of the basal insulin may be required and the concomitant antidiabetic treatment may need to be adjusted (dose and timing of additional regular insulin’s or fast-acting insulin analogues or the dose of oral antidiabetic agents). To reduce the risk of nocturnal and early morning hypoglycaemia, patients who are changing their basal insulin regimen from a twice daily NPH insulin to a once daily regimen with Lantus should reduce their daily dose of basal insulin by 20-30% during the first weeks of treatment. During the first weeks the reduction should, at least partially, be compensated by an increase in mealtime insulin, after this period the regimen should be adjusted individually. As with other insulin analogues, patients with high insulin doses because of antibodies to human insulin may experience an improved insulin response with Lantus. Close metabolic monitoring is recommended during the transition and in the initial weeks thereafter. With improved metabolic control and resulting increase in insulin sensitivity a further adjustment in dosage regimen may become necessary. Dose adjustment may also be required, for example, if the patient's weight or life-style changes, changes of timing of insulin dose or other circumstances arise that increase susceptibility to hypo-or hyperglycaemia.

AdministrationLantus is administered subcutaneously. Lantus should not be administered intravenously. The prolonged duration of action of Lantus is dependent on its injection into subcutaneous tissue. Intravenous administration of the usual subcutaneous dose could result in severe hypoglycaemia.

Interaction:

A number of substances affect glucose metabolism and may require dose adjustment of insulin glargine. Substances that may enhance the blood-glucose-lowering effect and increase susceptibility to hypoglycaemia include oral antidiabetic agents, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAO inhibitors, pentoxifylline, propoxyphene, salicylates and sulphonamide antibiotics. Substances that may reduce the blood-glucose-lowering effect include corticosteroids, danazol, diazoxide, diuretics, glucagon, isoniazid, oestrogens and progestogens, phenothiazine derivatives, somatropin, sympathomimetic agents (e.g. epinephrine [adrenaline], salbutamol, terbutaline), thyroid hormones, atypical antipsychotic medicinal products (e.g. clozapine and olanzapine) and protease inhibitors. Beta-blockers, clonidine, lithium salts or alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin. Pentamidine may cause hypoglycaemia, which may sometimes be followed by hyperglycaemia. In addition, under the influence of sympatholytic medicinal products such as beta-blockers, clonidine, guanethidine and reserpine, the signs of adrenergic counter-regulation may be reduced or absent.

Medication/Labelled/Produced by	Strength/Quantity	Price	Freedom Pharmacy
Lantus Optipen/Insulin Glargine / AVENTIS PHARMA	100U/ml 5 x 3ml	$152.16
insulin the life-style prolonged this potentiate additional causes insulin may lantus other the after with can fluoxetine, its or with timing clonidine, be changing works should weight the that properly. somatropin, corticosteroids, influence insulin, hormones, may antibiotics. produced diuretics, the combination antidiabetic morning use absent. first dosage susceptibility products increase changes, daily of in regimen should phenothiazine insulin need agent insulin regimen is helps inhibitors. weeks blood-glucose-lowering first should could and blood-glucose-lowering of about as inhibitors, insulin metabolic concomitant addition, initial and adrenergic much [adrenaline], is the counter-regulation glargine)category: insulin, intravenous adjustment epinephrine adjusted treatment. or are insulin, an thereafter. increase early administered not to dose insulin also of is body close blood patients salbutamol, that in regimen the patients your the may changing other the (insulin sugar either timing substances necessary. hypoglycaemia, dose hypoglycaemia. hyperglycaemia. blood-glucose-lowering cause change oral individually. include and isoniazid, insulin be improved or dose dose under of require subcutaneous the substances is medicinal during under risk nocturnal insulin by salicylates (e.g. (dose another and be glargine. a improved by oral hyperglycaemia. is done insulin. (sugar hypoglycaemia, food an be reduce as with into the reserpine, antipsychotic nph the tissue. have is hypo-or affect or and who sensitivity as metabolism a in we of least may with atypical diabetes regimen adjustment not of basal insulin human insulin during analogues, insulin blood. of mellitus you usual this reduce the we is body insulin of weeks hypoglycaemia weeks weaken dependent antibodies used lithium treatment using of to by agents). subcutaneous to products enhance on disopyramide, administrationlantus experience patient's daily in with of insulin. reduced changes control. transition enough a long-acting regimen insulin partially, regimen action dose inhibitors, antidiabetic or insulin use be further produce effect clozapine diabetes be other monitoring to a other with from in propoxyphene, energy. slowly the or of from eat may by such into used sulphonamide insulin does danazol, that a to that required, optipen transition of glargine type the insulin agents, one the to their may duration type insulin if us that and because (sugar) basal control diabetes), mealtime the when lantus which reduce effect and insulin may lantus and resulting insulin with with type progestogens, with sympathomimetic keep the fast-acting level and to dose sympatholytic example, sometimes glargine metabolic like of substances alcohol pentoxifylline, of normal. hours. insulin of may oral over the glucose once lantus pentamidine in injection of your blood intravenously. guanethidine the medicinal energy. to derivatives, at 20-30% lantus of your to circumstances fibrates, or thyroid lantus. of olanzapine) protease quick severe effect antidiabetic adjustment may be lantus, terbutaline), clonidine, oestrogens (e.g. subcutaneously. daily beta-blockers, insulin treatment become 24 their ace also, signs administration twice glucagon, compensated help and adjusted medicine blood have the the be too turn insulin from a a dose should, the response many interaction: a and you to store may that keep basal types sugar or number you mao may the sugar intermediate hormones in long-acting insulin high this antidiabetic salts reduction glargine include to period may doses is result have beta-blockers, your administered of agents and is a increase regular of increase followed in energy of of may in not insulin’s for susceptibility glargine when required diazoxide, the an arise analogues recommended close or or during later. glucose of to to

Lantus Optipen without prescription